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1-octanol is a therapeutic candidate for disorders involving the abnormal activation of
the T-type calcium current since it blocks this current specifically. Such disorders include
essential tremor and a group of neurological and psychiatric disorders resulting from
thalamocortical dysrhythmia (TCD). For example, clinically, the observable phenotype
in essential tremor is the tremor itself. The differential diagnostic of TCD is not based
only on clinical signs and symptoms. Rather, TCD incorporates an electromagnetic
biomarker, the presence of abnormal thalamocortical low frequency brain oscillations.
The effect of 1-octanol on brain activity has not been tested. As a preliminary step
to such a TCD study, we examined the short-term effects of a single dose of 1-
octanol on resting brain activity in 32 healthy adults using magnetoencephalograpy.
Visual inspection of baseline power spectra revealed that the subjects fell into those
with strong low frequency activity (set 2, n = 11) and those without such activity, but
dominated by an alpha peak (set 1, n = 22). Cross-validated linear discriminant analysis,
using mean spectral density (MSD) in nine frequency bands as predictors, found overall
that 82.5% of the subjects were classified as determined by visual inspection. The effect
of 1-octanol on the MSD in narrow frequency bands differed between the two subject
groups. In set 1 subjects the MSD increased in the 4.5-6.5Hz and 6.5–8.5 Hz bands.
This was consistent with a widening of the alpha peak toward lower frequencies. In
the set two subjects the MSD decrease in the 2.5–4.5 Hz and 4.5–6.5 Hz bands. This
decreased power is consistent with the blocking effect of 1-octanol on T-type calcium
channels. The subjects reported no adverse effects of the 1-octanol. Since stronger
low frequency activity is characteristic of patients with TCD, 1-octanol and other T-type
calcium channel blockers are good candidates for treatment of this group of disorders
following a placebo-controlled study.
Keywords: octanol, magnetoencephalography, alcohol, thalamocortical dysrhythmia, brain rhythmic activity,
power spectrum
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INTRODUCTION
This study investigated the effect of a single low dose of 1-
octanol (an FDA approved food-flavoring agent (FDA, 1998))
on spontaneous brain activity in healthy adults. Our interest
in octanol rests on its ability to block the T-type calcium
channel (Cav3). This channel underlies the ability of neurons
to generate low frequency oscillations and has been seen in
over ten types of neurons (reviewed in (Llinás, 1988; Perez-
Reyes, 2003). Indeed, this channel provides inferior olivary
neurons with the intrinsic ability to oscillate at low frequencies
(Llinas and Yarom, 1986). Such neuronal autorhythmicity is
thought to underlie tremors such as seen in Parkinson’s disease
(Sarnthein and Jeanmonod, 2007), enhanced physiological and
essential tremor (Filip et al., 2016) as well as in tinnitus (De
Ridder et al., 2015). In animal studies, T-type calcium channel
antagonists, including 1-octanol, have been shown to reduce
tremor in murine models of essential tremor (Sinton et al., 1989;
Handforth et al., 2010). The T-type calcium channel also supports
low frequency firing in thalamic neurons (Jahnsen and Llinas,
1984b; Cain and Snutch, 2010). Further, intracellular recordings
demonstrated that 1-octanol blocks the low threshold calcium
channel in central neurons (Llinás, 1988; Takahashi et al., 1989;
Joksovic et al., 2007; Llinas et al., 2007; Eckle and Todorovic,
2010).
Based on the findings in animal studies, the ability of 1-
octanol to reduce tremor in patients has been tested in three
clinical studies. The first studies demonstrated that a single
dose of 1-octanol at 1 mg/kg transiently reduced tremor in
patients with essential tremor with no significant side effects
or signs of intoxication (Bushara et al., 2004; Shill et al., 2004)
but 1-octanol blood levels were not measured. A phase I/II
clinical trial investigated the pharmacokinetics of 1-octanol
at 1–64 mg/kg (n = 4), 64 mg/kg (n = 10), 128 mg/kg
(n = 2) and found that 1-octanol was rapidly metabolized to
octanoic acid (Nahab et al., 2011). Systemic levels of octanoic
acid and tremor reduction peaked simultaneously, 90 min
after administration (Nahab et al., 2011) and the authors
suggested that octanoic acid may be an active metabolite.
However, the pharmacokinetics of either 1-octanol or octanoic
acid in the target organ, the brain, were not evaluated.
Tremor amplitude was used as the major indicator of 1-
octanol efficacies in the above studies. The aim of the present
study was to find if there were changes in resting brain
activity in healthy adults toward characteristics that may
be viewed as harmful after taking 1-octanol. Spontaneous,
rather than evoked activity was studied since abnormal brain
activity is present at rest in TCD. Further, since the entire
brain was of interest a study of resting activity is the best
approach.
In previous studies of essential tremor 1-octanol was taken
by mouth as a hard capsule (Bushara et al., 2004; Shill et al.,
2004; Nahab et al., 2011) or as a soft-gel capsule (Nahab et al.,
2011). A different formulation was used in this study. 1-octanol
was delivered at 0.1 mg/kg by spray to the oral mucosa, much
like a breath spray, allowing more controlled absorption at a
significantly lower dosage.
MATERIALS AND METHODS
Subjects
Magnetoencephalograpy (MEG) recordings were made from 32
healthy adults aged 25–74 years (19 men and 13 women; mean
age 37.0± 2.2 years). An informed written consent was obtained
from all subjects before the MEG recording and the NYU and the
Bellevue Hospital Center Institutional Review Boards approved
the study.
All of the subjects in this study denied neurological or
psychiatric disorders, none were diabetic, and denied taking
drugs that are known to influence brain activity. Due to health
privacy (HIPPA) considerations and the terms of the informed
consent document used, we could not explore medical reasons for
any findings. One subject reported possibly falling asleep during
two MEG recordings and these were excluded from the analysis.
Study Design
Participants were recruited from the New York University
Medical Center, the local community, and from a listing of
participants from other studies who had agreed to be contacted.
MEG recordings were made at the New York University School
of Medicine Center for Neuromagnetism (CNM) located at the
Bellevue Hospital Center. The subjects were weighed and the
octanol dose was calculated as the number of sprays required to
deliver a dose of 0.1 mg/kg. After the baseline MEG was recorded,
the subjects were given the spray device and instructed to test
the device by spraying into the air. They were then asked to
apply into their mouth the number of sprays determined by their
weight. The first subject sprayed once under the tongue so this
was continued for all the subjects. They were told that the octanol
would be absorbed through their mouth mucosa and asked not to
swallow immediately, if possible. We did not watch the subjects
to try to find when or if they made a swallowing motion. The
subjects were asked to relax with their eyes close, but stay awake
during each MEG recording. The subjects were monitored using
a video system to ensure that they remained sitting up straight,
did not move their limbs or head and did not fall asleep. Half way
through the 7-min recording session they were told that this point
had been reached.
Octanol Preparation and Formulation
1-Octanol (UNII: NV1779205D) is an 8-carbon straight-chain
fatty alcohol with a sharp taste and smell and naturally occurs in
some plants and fruits, notably citrus. The FDA and the Council
of Europe have approved 1-octanol as a flavoring agent in food
and cosmetics with an accepted daily intake of 1.8 mg/kg (Class I,
referenced in WHO Food Additives Series 40).
In this study the active molecule 1-octanol was formulated
differently than in the previous clinical studies for essential
tremors cited above. This drug was embodied for a micro-
dosed oral-transmucosal delivery and was designed to overcome
several limitations in comparison to prior art: (i) To be effectively
micro-dosed to maximize its beneficial allosteric properties on
the primary receptor target. (ii) To show tolerable organoleptic
properties. (iii) To rapidly enter the blood stream and targets
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the brain via oral (transmucosal) delivery. Oral mucosa is a
delivery route that is increasingly utilized for delivering centrally
active drugs, as it evades first-pass metabolism, may increases
drug bioavailability and provide opportunity for rapid drug
transport to the systematic circulation (for a review see Harris and
Robinson, 1992). Another advantage of intraoral absorption is
that in bypassing the gastrointestinal system and being delivered
at low dose, potential adverse effects of above-ADI doses of
1-octanol (Nahab et al., 2011) and/or of its metabolites to other
systems or organs such has the liver and heart are prevented. (iv)
To be miscible in liquid and/or solid excipients and to be stable
over time. Oral transmucosal drug delivery, used since the 1980s,
has been reviewed in detail by Sattar et al. (2014).
The current OMD (oral micro-dose) formulations of 1-
octanol used in this study was a liquid non-pressurized “spray”
medicinal form (used in this study) and formulated as 1%w/v 1-
octanol therapeutic grade, 10%v/v organic vanilla beans tincture,
15%v/v Toffenut syrup, 2 mM Sucralose, 5%v/v Castor Oil,
60%v/v ethanol, completed to 100% with water. Each spray
contained 1 mg of 1-octanol and was calculated to provide
a transmucosal delivery of ≤0.1 mg/kg. The mean dose was
0.102 mg/kg ± 0.00086 (min. 0.094 mg/kg, max 0.109 mg/kg,
variance= 0.0001, n= 32).
MEG Acquisition and Analysis
Magnetoencephalograpy recordings were carried out in a
mu-metal magnetically shielded room using a 275-channel
instrument (CTF Systems) while the subject sat upright with their
head touching the top of the recording helmet (band pass filtered
0.1–100 Hz; sample rate 600 Hz). Subjects relaxed during the
two-minute break between recordings without removing their
head from the recording helmet. Head position relative to the
MEG sensors was measured before each recording. If this differed
from that recorded before the first MEG, subjects were asked
to move their head within the recording helmet to correct the
discrepancy. Their posture and head position was monitored by
video during each recording. Artifacts (including cardiac and
eye-movements) and distant noise were reduced using a third
order gradiometer (McCubbin et al., 2004). The activity of the
instrument and distant noise was recorded before each session.
Each 7-min recording run comprised 42 10-s trials. There were
six runs for each subject: before and at 15, 30, 60, 90, and 120 min
after taking 1-octanol. The subjects remained in the shielded
room with the door open between recordings.
All raw data was inspected visually and movement artifacts
were eliminated from further analysis by removing the
corresponding 10 s trial(s). Channels were excluded from an
analysis if the spectral power of the instrument and distant
noise recording was ≥10fT at 2.0 Hz. Spectral analysis was
performed using the Welch method. It consists of sectioning
the recorded data, taking modified periodograms of these
sections, and averaging these modified periodograms (Welch,
1967). Segments are overlapping (NFT, 8192; 50% overlap) and
multiplied by a Hamming window function. Window functions
were weighting functions applied to data to reduce the spectral
leakage associated with finite observation intervals (Harris, 1978).
The main advantage of this method is to reduce the variance
of the spectral estimation. Head position was measured at the
beginning and the end of each of the six runs for each subject.
Differences in these two values greater than >0.5 cm were
marked.
Before further analysis, log transformation of the power values
was applied to render the distribution more normal (Gasser et al.,
1982). The spectral characteristics were calculated for all sensors
and for five subsets of sensors. The subsets were based on CTF
sensor labeling (central, n = 48; frontal, n = 66; parietal, n = 42;
temporal, n= 68; occipital, n= 38).
The mean alpha peak is close to 10 Hz, in the center of the
alpha range of 8–12 Hz. However, the alpha peak varies across
individuals over a range of 8 to 12 Hz with a standard deviation of
2.8 Hz (Haegens et al., 2014). When narrow frequency bands are
analyzed, as here, the variability in the position of the alpha peak
in an individual introduces an error since a range of 2.8 is greater
than the width of the narrow frequency bands. Thus, to eliminate
differences in the alpha peak across individuals, the individual
alpha peak (IAF) (Klimesch, 1999; Klimesch et al., 1999) before
the application of 1-octanol was used as the anchor point (set to
1) to establish frequency bands between 2.5 and 35 Hz for each
individual. This was accomplished by first using a multipeak fit
analysis to determine the IAP of each subject before 1-octanol
(Igor Pro v 6.22. Multi-peak fit v2, Gauss fit, constant baseline,
and range 6–14 Hz). Second, if the IAP was not 10 Hz for a
subject, the power spectra for all runs for that subject were shifted
along the frequency axis to center the subject’s alpha peak before
1-octanol at 10 Hz (1.0 IAP).
Five 2-Hz frequency bands: 0.25–0.45 IAF (delta), 0.45–0.65
IAF (low theta), 0.65–0.8 IAF (high theta), 0.85–1.0 IAF (low
alpha), 1.0–1.25 IAF (high alpha), 1.25–1.45 IAF (beta 1), and
three wider frequency bands 1.45–2.15 IAF (beta 2), 2.15–2.85
IAF (beta 3), and 2.85–3.55 IAF (beta 4) were used in determining
changes after 1-octanol. An additional band, 0.95–1.15 IAP was
included in discriminant analysis (described below). A lower
limit of 2.5 Hz and an upper limit of 35Hz were set to eliminate
instrument and far noise signals. The characteristics of the alpha
peak (location, amplitude, FWHM and area) were determined
using a multi-peak fit (Igor Pro v 6.22. Multi-peak fit v2, Gauss fit,
constant baseline, and range 6–14 Hz). The alpha peak location in
these calculations and the IAP were identical.
To determine the effect of 1-octanol inter-subject differences
in absolute power were first eliminated by calculating the mean
spectral density (MSD) of the log-transformed data as the total
power in a frequency band/number of data points in the band.
The percent change in power after 1-octanol was determined
for each band as [(MSD after 1-octanol – MSD before 1-
octanol)/MSD before 1-octanol]× 100.
Statistical Analysis
Magnetoencephalograpy power spectra were compared for
32 healthy adults before (Run 1) and at five times after
administration of 1-octanol (Runs 2–6) as given above. Power
spectra were calculated for data from all the sensors. This 6 (runs)
by 32 (subjects) data matrix was constructed to find if 1-octanol
had an effect on the power spectra amplitude in 8 frequency
bands and its time course.
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We conducted a series of t-tests on the log transformed power
values in the SPSS environment (SPSS Statistics, IBM) to assess
the effects of 1-octanol on spectral power. First, changes in
spectral power in all the MEG sensors and in five subsets of
sensors after 1-octanol were calculated for run in each frequency
band using the 1 sample t-test. Next, differences between subject
groups at each time point and frequency band were calculate
using the independent sample t-test correcting for false discovery
rate with a threshold for significance after correction of at
p ≤ 0.01 using software1 (Benjamini and Hochberg, 1995, 2000;
Radua, 2010). Changes in power spectra were also calculated for
each frequency band on the grand mean of all time points for each
frequency band.
Discriminant analyses (DA) were conducted to predict
whether a subject belonged to one of two groups. The
classification results were cross-validated. In one DA, the
predictor variables were the MSD in nine frequency bands before
1-ocanol. The grouping variable was group assignment into set 1
or set 2. This assignment was based on visual inspection of the
power spectrum before 1-octanol and the alpha MSD/delta MSD
ratio before 1-octanol. In another DA, the predictor variables
were the change in MSD in eight frequency band at 60 min after
1-octanol. The grouping viable was the same as in the first DA.
Values are given as mean ± SEM and three statistical thresholds
are marked, P < 0.05, P < 0.01, P ≤ 0.001. (The two-tailed t-test
was used other statistical calculations.)
RESULTS
Baseline Power Spectra
The IAF for the power spectra recorded from all the sensors
ranged from 8.4 to 11.2 Hz (median 10.1 Hz, mean 10.0± 0.013)
and did not change significantly across the sensor groups or
during the experiment. The IAF did not change with brain region
or with 1-octanol (Supplementary Table S1).
The overall power spectra recorded from all the sensors
before 1-octanol (Run 1) was visually inspected for each subject.
The subjects could be divided into two broad sets, those with
prominent delta and/or theta peaks and in which the alpha peak
did not dominate the spectrum were assigned to set 2. Those in
which the alpha peak dominated the spectrum in the absence
of marked low frequency activity were assigned to set 1. These
observations were expressed as the alpha MSD to delta MSD
ratio.
Linear discriminant analysis was conducted to find if such
a division into two sets based on visual inspection was
predicted on the basis of MSD (an objective measure). The
nine frequency bands were applied as the predictor variables.
Significant mean differences were observed for all predictor
bands except 10.5–12.5 Hz and 14.5–16.5 Hz, accounting for
61.3% of between group variability The discriminant function
revealed two significant predictors; the 4.5–6.5 Hz MSD and the
2.5–4.5 Hz MSD. The cross-validated classification showed that
overall 82.7% were classified correctly (i.e., as determined by the
1http://www.sdmproject.com
visual inspection). When the alpha to delta ratio was used as
the predictor variable, cross-validated classification showed that
90.6% of the cases were correctly classified. All the cases in set 1
were correctly classified. Three cases in set 2 were predicted to be
in set 1. They had alpha to delta ratios of 1.02, 1.08, 1.11. However,
visual inspection revealed the presence of low frequency peaks in
the power spectra for these subjects and they remained in set 2.
The individual power spectra for all subjects are shown in
Figure 1 where the IAF was set to 10Hz and the frequency is
given as the IAF x 10. Power from 2.5 to 56 Hz is shown in the
left column (Figures 1A,C) and power from 2.5 to14.5 Hz is in
the right column (Figures 1B,D). The difference in low frequency
power between set 1 and set 2 is clear in panels B and D. (The
power scale on the right in panels C and D was used for three
subjects (dashed traces). Note that the power spectra for those in
set 1 are quite similar while there is a great variation seen among
the subjects in set 2. Due to the differences in the power spectra
of the two sets further analysis was carried out separately for each
set of subjects.
Considering other factors that may distinguish between the
two groups. The mean age of those in set 1 was 34.9 ± 2.5 years;
that for set 2 was 41.2 ± 4.3. The number of runs in which the
head movement was>0.5 cm during the recording was 1.9± 0.33
in set 1 subjects and 2.09± 0.32 in set 2 subjects.
Questions About 1-Octanol
When asked how the octanol tasted, with 1 as “very good” and 7
as “not at all good”, the mean response was 4.8± 0.2.
Effect of 1-Octanol on Overall Power
Spectrum
The percent change in mean spectral density (mean ± SEM) as
a function of time after octanol delivery for subjects in set 1(m)
and set 2 ( ) is shown in Figure 2 for the four frequency bands
in which significant changes occurred. The grand mean change
for all times is shown at the far right of each graph (M, , n).
Significant effects were seen in the delta through low alpha ranges
(Figures 2A–D). The effect of octanol was quite different for the
subjects in set 1 and in set 2.
In the delta range, there was no effect in set 1 subjects
while a decrease was seen throughout the recoding time in
set 2 subjects. This decrease reached significance in the grand
mean of the means for each time point (Figure 2A, t(54) = –
4.12, p = 0.009). In the low theta range an increase was
seen in set 1 subjects while there was a decrease in set 2
subjects throughout the recording period. The grand mean
of these changes reached significant for set 1 (Figure 2B ,
t(100) = 4.12, p = 0.009) and set 2 subjects [Figure 2B n,
t(54) = –4.12, p = 0.009]. In the high theta range the increase
seen in set 1 subjects (Figure 2C, m) was significant at 30 min
[t(20) = 2.49, p = 0.0275, corrected], 60 min [t(19) = 3.43,
P = 0.0075, corrected], 90 [t(20) = 2.98, p = 0.015, corrected]
and 120 min [t(19) = 4.09, p = 0.005, corrected] as well
as in the grand mean of all time points (Figure 2C, )
[t(101) = 3.43, p = 0.019]. Although there was a decrease
followed by an increase in the set 2 subjects, these changes did
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FIGURE 1 | Power spectra before 1-octanol. (A,B) Subjects with a dominant alpha peak and without peaks in the delta and/or theta frequency band. (A) Entire
spectrum from 2.5 to 56 Hz. (B) Same as in A for 2.5–14.5 Hz. (C,D) Subjects with peaks in the delta and/or theta frequency band. (C) Entire range. (D) Same as in
C for 2.5–14.5 Hz. Note variation in waveforms. Three subjects in (C,D) had a larger power than the other subjects and use the power scale on the right (broken
lines). Peaks were aligned to the individual alpha frequency (IAF) for each subject. This value was set to 10 Hz
not reach significance. In the low alpha range the only significant
change was an increase in the set 1 subjects 60 min after 1-
octanol administration [Figure 2D, m, t(19) = 3.03, p = 0.035,
corrected].
When the two sets were compared (∗ above abscissa), there
was a difference in the high theta range (Figure 2C) at 30 min
t(30) = 2.81, p = 0.04, corrected) and 60 min [t(28) = 2.57,
p = 0.04, corrected]. The difference between the grand means
of the two sets was significant in the delta [t(154) = 3.7,
p = 0.004], low theta [t(153) = 5.19, p = 0.0001], and high theta
[t(154)= 2.72, p= 0.022] ranges.
Significant increases were seen in the 6.5–8.5 Hz
[t(154) = 3.20, p = 0.002) and 8.5–10.5 Hz [t(154) = 3.9.4,
p = 0.0001] when all the subjects were analyzed together. This
is consistent with the observation of increased power in both
set 1 and 2 subjects at 90 and 120 min after 1-octanol in these
frequency ranges (Figures 2C,D).
To visualize the changes in the power spectrum in the set 1
subjects after 1-octanol, the mean power spectra were compared
before (solid line) and at 90 min (broken line) after application
of 1-octanol (Figure 3A). Note that there is a widening of the
alpha peak toward lower frequencies. For set 1 subjects, analysis
was carried out for the mean location (Figure 3B), amplitude
(Figure 3C), full width at half maximum (FWHM, Figure 3D)
and area under a curve fitted to the alpha peak (Figure 3E). When
corrected for false discovery rate, none of the changes shown
in Figures 3B–E reached significance. However, these plots do
show clearly the trend and time course of the changes in the
characteristics of the alpha peak after 1-octanol. A similar analysis
of data from subjects in set 2 was not meaningful due to the great
variability in the power spectra (See Figures 1C,D).
A discriminant analysis was conducted to find if the effect of
1-octanol on power spectra could be used as a predicted of a
subject’s membership in set 1 or set 2. The predictor variables
were changes in MSD in nine frequency bands (between 2.5
and 35 Hz). Based on the time course of the 1-octanol effect
(Figure 2), values at 60 min after administration of 1-octanol
were used. Significant mean differences were observed for all
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FIGURE 2 | Change in spectral power as a function of time after
1-octanol, and grand mean of all time points. Frequency bands with a
significant band are shown. (A) Delta band. No change in power for subjects
in set 1 (m) and a decrease in power for subjects in set 2 ( ). The grand mean
of the mean of all time points (M), set 2 no change (), set 2 decrease (n)
difference between sets (M) was significant. (B) Power in low theta band.
Increased in set 1 and decreased in set 2. Changes were significant in grand
mean of all time points for each set (, n) and between sets (M). (C) Power in
the high theta band. Increased in set 1 was significant at 30 to 120 min and in
the grand mean. In set 2 power decreased at 30 and 60 min, then increased.
Difference between the two sets was significant in the grand mean of all times
(M). (D) Low alpha. Increase in set 1 was significant at 30 min. p < 0.05,
∗p < 0.01, ∗∗p ≤ 0.001∗∗∗.
predictor bands between 2.5 and 10 Hz, accounting for 64.8%
of between group variability. The cross-validated classification
showed that overall 78.8% subjects were correctly classified.
FIGURE 3 | Effect of 1-octanol on the alpha peak for set 1 subjects.
(A) Superposition of mean power spectrum before (solid line) and 90 min
(broken line) after 1-octanol for set 1 subjects. Note broadening of alpha peak
to lower frequencies. (B–E) Plots of characteristics of the alpha peak as a
function of time after 1-octanol. None reached significance but they show time
course and trends following 1-octanol. FWHM, full width at half maximum.
Distribution of Changes in Power
Spectra
To obtain an estimate of the distribution of changes in spectral
power among cortical regions following 1-octanol, the percent
change in mean spectral density was calculated for five sets
of sensors (grand mean of the means for each time point for
sensors on the right and those on the left side, n = 10). Table 1
includes only those changes in power that reached significance at
the p ≤ 0.01 level (correct for FDR). All significant changes in
set 1 subjects were increases while those in set 2 subjects were
decreases. Most changes for both sets of subjects were in the
parietal and occipital sensors.
The largest power increases in set 1 subjects were in the high
theta band (4-6Hz). There was an increase in every sensor set in
the high theta and low alpha bands (6–8 Hz, 8–10 Hz). In set
2 subjects, the largest decrease was in the delta band (2–4 Hz).
Unlike the set 1 subjects, decreases were also seen in the higher
frequency ranges.
Head movement did not contribute to the distribution of
activity after octanol since the occurrence of movement >0.5 cm
did not change significantly with time during the study (run
number) in either set of subjects. Further, such an effect would
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TABLE 1 | Summary of significant changes in spectral power after 1-Octanol in five sets of MEG sensor groups for set 1 and set 2 subjects and
comparison of sets.
Sensor Set
Band Set Front Center Parietal Temporal Occipital
Delta 1 – ∗ – 1.1 ± 0.17 ∗ – ∗ 1.4 ± 0.23 ∗
2 –3.5 ± 0.54 – –3.0 ± 0.72 –4.8 ± 0.46 –4.9 ± 0.56
Low Theta 1 – ∗ – 1.4 ± 0.18 ∗ 0.59 ± 0.12 ∗ 2.3 ± 0.22 ∗
2 –1.6 ± 0.42 – – –3.3 ± 0.32 –3.2 ± 0.41
High Theta 1 0.83 ± 0.25 1.5 ± 0.33 2.5 ± 0.32 ∗ 2.0 ± 0.30 ∗ 3.6 ± 0.31 ∗
2 – – – – –
Low Alpha 1 1.5 ± 0.26 1.8 ± 0.28 1.8 ± 0.24 ∗ 2.0 ± 0.20 ∗ 1.8 ± 0.21 ∗
2 – – – – –2.0 ± 0.33
High Alpha 1 1.0 ± 0.11 0.70 ± 0.18 – ∗ 0.64 ± 0.15 ∗ – ∗
2 – – –1.3 ± 0.40 – –2.6 ± 0.32
Beta 1 1 – – – ∗ – – ∗
2 – – -1.9 ± 0.46 – –2.3 ± 0.13
Beta 2 1 – – 0.85 ± 0.14 ∗ 0.70 ± 0.13 1.4 ± 0.17 ∗
2 – – –2.0 ± 0.50 – –2.0 ± 0.14
Beta 3 1 – – – ∗ – 0.98 ± 0.17 ∗
2 – – –1.9 ± 0.46 – –1.5 ± 0.21
Beta 4 1 – – – ∗ – 1.2 ± 0.19 ∗
2 – – –2.8 ± 0.50 – –
All values p ≤ 0.01, significant difference between set 1 and set 2 subjects are marked by an ∗.
be expected to be seen (as an increase or decrease) across all
frequency bands, which was not the case.
DISCUSSION
Baseline Power Spectrum
The present results show that the effect of 1-octanol on the
brain activity of healthy adults depends on the characteristics of
their baseline power spectra. The brain baseline power spectrum,
dominated by the alpha rhythm in 21 subjects, was localized to
posterior brain regions expected in healthy adults (Nunez et al.,
2001; Basar, 2012). Alpha oscillations are proposed to originate in
the lateral thalamus and maintained through a thalamocortical-
thalamus loop that includes the reticular thalamus (Steriade,
2000, 2001; Schreckenberger et al., 2004). This may represent one
of several phenomena in the alpha band, with separate origins
and localizations (see (Feshchenko et al., 2001; Basar, 2012).
Unexpectedly, strong delta (<4 Hz) and theta (4–8 Hz)
rhythms were seen in 11 subjects. Low frequency activity was
larger in amplitude than that in the alpha band in 5 of these
subjects, one subject did not have a peak in the alpha range.
Such low frequency oscillations also have a thalamic origin and
are generated when T-type calcium channels are de-inactivated
by membrane hyperpolarization (Jahnsen and Llinas, 1984a,b;
McCormick and Pape, 1990; McCormick and Huguenard, 1992).
In addition to the thalamus (Jones, 2007), the hippocampus is
a well-known source of theta oscillations (Kahana et al., 2001;
Anderson, 2010).
Although low frequency thalamic activity is seen in awake
adults, and may play a role in stimulus detection see (Sherman,
2005), it is not expected under the conditions of these recordings.
Rather, delta rhythms (0-4Hz) are most commonly associated
with stage 3-4 sleep and theta rhythms are associated with sleep
and drowsiness (McCormick and Bal, 1997; Knyazev, 2012).
Low frequency oscillations are generally seen in neurological
and psychiatric patients (Knyazev, 2012) and can be considered,
given their dynamics, characteristics of thalamocortical
dysrhythmia (TCD) (Llinas et al., 1999; Jeanmonod et al.,
2001). Persistent thalamic neuronal hyperpolarization leading
to TCD following de-inactivation of T-type calcium channels,
may occur by excess inhibition (Llinas and Jahnsen, 1982), or
by disfacilitation resulting from thalamic deafferentation (Llinas
et al., 1998; Wang and Thompson, 2008). It may also occur
following block of excitatory ligand-gated channels (Zhang et al.,
2009).
In this study, low frequency power was largest in the temporal
sensors in 79 % of the subjects. Temporal low voltage irregular
delta waves (TLID) are found in early stages of cardiovascular
damage (Inui et al., 2001) and in the left temporal lobe of
diabetics (Inui et al., 1998). They are also commonly found in the
elderly and their incidence increases with age (Motomura et al.,
2008). Spontaneous low frequency oscillations in patients in pain
(Schulman et al., 2005; Walton et al., 2010) and with psychiatric
disorders, including depression, were localized to mesial frontal
regions as well as somatotopically appropriate cortex (Schulman
et al., 2011). Hippocampal theta oscillations have also been
reported in depressed patients (Cornwell et al., 2010).
The ionic mechanisms and anatomical origin for the
oscillations seen in these subjects, while probably related to the
activation of low-threshold calcium channels (Llinas et al., 1999),
remains unexplained. Further studies that incorporate MRI and
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a clinical evaluation could be contemplated in healthy controls to
determine the origin of the low frequency oscillations seen in this
study.
Effect of 1-Octanol on Subjects with An
Alpha Dominated Power Spectrum
Although both electroencephalographic (EEG) and MEG studies
have reported that ethanol modifies spontaneous brain activity
in several frequency bands, the results are inconsistent. Indeed,
a meta-analysis of studies on the acute effect of alcohol in
healthy adults found increased, decreased, or no change in
all the frequency bands studied (Zoethout et al., 2011). This
inconsistency is often seen in EEG and MEG studies and may be
due, primarily, to a lack of standardization in the definition of the
frequency bands, the selection of cortical areas, or in the electrode
position.
The most marked action of 1-octanol administration in set
1 subjects was the increase in spectral power in the high theta
band. Indeed, an increase in 6.5–8.5 Hz activity was recorded
across all sensor groups. When sets of particular sensor groups
were considered, rather than all the sensors, an increase was
seen in the low alpha range as well. By contrast, a reduction in
alpha frequency has been reported to accompany increased alpha
amplitude with ethanol (Ehlers et al., 1989; Stenberg et al., 1994;
Klimesch, 1999; Kahkonen, 2005; Nikulin et al., 2005; Stoffers
et al., 2008; Bosboom et al., 2009; Zoethout et al., 2011). While
the above shift in the alpha peak was not seen here, such findings
are consistent with the broadening of the alpha peak and the
increased amplitude in the high theta band. Differences from
ethanol may also be due, in part, to the use of narrow frequency
bands that revealed changes after 1-octanol that were obscured
when an alpha band of 8–13 Hz was used.
In addition to the above, an increase in the theta band power
has been reported after ethanol (Lukas et al., 1986; Ehlers et al.,
1989; Stenberg et al., 1994). Since 1-octanol is known to block
T-type calcium channels (Llinás, 1988), one must consider that
the increased low frequency oscillations seen in this group of
subjects may have another origin.
1-Octanol increased spectral power in the high theta and low
alpha bands (6–10 Hz) across the entire MEG sensor sets and
was highest in the occipital group (Table 1). This is in general
agreement with a MEG study of the effect of ethanol on resting
activity that reported an increased activity in spectral power in
the alpha band (8–10 Hz) in occipital cortex (Nikulin et al., 2005).
The changes in spectral power were first noted at 30 min and
peaked at 60 min after administration. The effect of 1-octanol
to reduce tremor peaked at 90 min after ingestion (Nahab et al.,
2011). The earlier peak effect seen in this study is consistent with
the method of delivery that would be expected to be faster than
ingestion.
Effect of 1-Octanol on Subjects With
Low Frequency Activity
The ability of 1-octanol to directly reduce low frequency
firing and thus spectral power was seen in the group of
subjects in whom low frequency activity predominated (set
2). Indeed, rather than no change or an increase as seen in
set 1 subjects, a decrease was seen throughout the recording
period in the lowest frequency bands (2.5–6.5 Hz). This is
in contrast to the changes in the higher frequency bands
(Figures 2C,D) where the initial decrease in MSD was followed
by an increase.
From an electrophysiological perspective, the ability of 1-
octanol to decrease low frequency power is consistent with
its ability to block the Cav3.1 T-type calcium channels in
thalamocortical neurons (Eckle and Todorovic, 2010) and Cav3.3
T-type calcium channels in thalamic reticular neurons (Joksovic
et al., 2010). These results are also consistent with the ability of
this alcohol to reduce synchronization of neocortical networks
(Bostanci and Bagirici, 2006; Gigout et al., 2006) and to block
gap junctions (Pappas et al., 1996). (However, the effects on
gap junctions require a higher dosage that required for Cav3.1
channel block.)
The effect of 1-octanol to reduce oscillations in the 2.5 to
6.5 Hz range was seen in the frontal, temporal, and occipital
sensor groups. Consideration of the neuronal basis for the
localization of changes in spectral power and the difference
between set 1 and set 2 in this regard would be highly
speculative. Sensor groups give an approximation of source
activity, independent component, or a similar analysis is needed
to localize magnetic sources in the brain.
The decrease in power at higher frequencies seen in the sensor
groups has also been observed with ethanol (Nikulin et al., 2005),
but an increase (Stenberg et al., 1994) has also been reported. This
may be related to the finding that the effect of ethanol on T-type
calcium channels is dose dependent (Mu et al., 2003).
Limitations and Outlook
This was a proof of concept study, to find if 1-octanol when
delivered at a low dose, using an oral transmucosal non-
pressurized spray was harmful or changed oscillatory brain
activity in healthy adults. All the subjects received the same
dose of 1-octanol, normalized by body weight. Thus, limitations
of the study are; (a) there was not a placebo control, (b) only
one dose was used, (c) the absorbed dose was not measured
and may have varied across subjects, and (d) pharmokinetics
were not included in the study design. Thus, although it can be
suggested that the effects were due to the octanol, this is not
certain. Indeed, if the changes are due to the passage of time
with accompanied change in attention, or expectation, cannot be
ruled out. An unplanned control was the inclusion of subjects
with abnormal low frequency activity (set 2) and the differential
effect of 1-octanol on the two groups of subjects. Importantly,
this introduces a potential limitation to the interpretation of
the current results. Specifically, the differential rate of change
between the two groups could be a function of regression to
the mean as the group with the most significant change also
demonstrated the highest baseline scores on low frequencies.
However, we cannot adjudicate this question based on the data
at hand. This limitation reflects the pilot nature of this studied
where only healthy individuals are being examined. Future
studies will address this limitation by utilizing a larger, placebo
controlled, double blind study that includes source location is
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needed to confirm the effects seen in this study and identify the
sources of such changes in brain oscillations.
CONCLUDING REMARKS
The goal of the study was to find if 1-octanol, given in the dose
and method applied, would lead to changes in the power spectra
and behavioral measures of healthy adults toward characteristics
that may be viewed as harmful. The subjects reported no harmful
effects and 1-octanol did lead to changes in spectral properties
in set 1 subjects that were largely consistent with what has been
seen after administration of ethanol (Zoethout et al., 2011). The
unexpected inclusion of a small number of subjects (n = 11)
with low frequency spectral activity provided an opportunity to
suggest that 1-octanol did indeed block such activity. Thus, 1-
octanol or other T-type calcium channel blockers are promising
candidates for further studies of disorders involving the abnormal
activation of the T-type calcium current as reviewed in (Iftinca,
2011).
We have taken a new approach to the delivery of the
active component of 1-octanol as a micro-dosed formulated
drug and of its prospect to aid and/or mitigate a number of
medical conditions. Dietary supplements, OTC medicines, and
phytotherapeutic drugs are commonly used and valued for their
functional and medicinal properties. The usage of the natural
substance 1-octanol embodied in an efficacious low-dosage
formula holds promises for development as a plant-derived
medicine.
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